Discovery of 7-alkoxybenzofurans as PDE4 inhibitors with hepatoprotective activity in D-GalN/LPS-induced hepatic sepsis
- 7 June 2024
- journal article
- research article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 275, 116576
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Discovery of novel 2,3-dihydro-1H-inden-1-ones as dual PDE4/AChE inhibitors with more potency against neuroinflammation for the treatment of Alzheimer's diseaseEuropean Journal of Medicinal Chemistry, 2022
- Maresin 1 protects against lipopolysaccharide/d-galactosamine-induced acute liver injury by inhibiting macrophage pyroptosis and inflammatory responseBiochemical Pharmacology, 2022
- Development of highly potent phosphodiesterase 4 inhibitors with anti-neuroinflammation potential: Design, synthesis, and structure-activity relationship study of catecholamides bearing aromatic ringsEuropean Journal of Medicinal Chemistry, 2016
- Developing a New Definition and Assessing New Clinical Criteria for Septic ShockJAMA, 2016
- Bioactive benzofuran derivatives: An insight on lead developments, radioligands and advances of the last decadeEuropean Journal of Medicinal Chemistry, 2015
- Biological and medicinal significance of benzofuranEuropean Journal of Medicinal Chemistry, 2015
- MAO Inhibitory Activity of 2‐Arylbenzofurans versus 3‐Arylcoumarins: Synthesis, in vitro Study, and Docking CalculationsChemMedChem, 2013
- Structural Basis for the Activity of Drugs that Inhibit PhosphodiesterasesStructure, 2004
- UCSF Chimera—A visualization system for exploratory research and analysisJournal of Computational Chemistry, 2004
- Protection by a cyclic AMP-specific phosphodiesterase inhibitor, rolipram, and dibutyryl cyclic AMP against Propionibacterium acnes and lipopolysaccharide-induced mouse hepatitisInflammation Research, 1999